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Phosphatidic acid formation by phospholipase D is required for
transport from the endoplasmic reticulum to the Golgi complex
Kun Bi, Michael G. Roth and Nicholas T. Ktistakis*
Background: Lipid molecules may play a regulatory role in the secretory
pathway of mammals and yeast. The lipid hydrolase phospholipase D (PLD) is
one candidate for mediating regulation of secretion, based on the location of this
enzyme and its requirements for activation. 
Results: We found that primary alcohols, which block formation of phosphatidic
acid (PA) by PLD, inhibited the transport of two different viral glycoproteins from
the endoplasmic reticulum to the Golgi complex in Chinese hamster ovary cells.
Corresponding secondary alcohols, which are much less potent in blocking PA
formation, were also less effective in blocking transport of the glycoproteins. The
block in glycoprotein transport imposed by primary alcohols was reversed when
PA, in the form of liposomes, was exogenously supplied to the culture medium.
Conclusions: We suggest that the earliest site of regulation of membrane
transport by PLD is within the intermediate compartment between the
endoplasmic reticulum and the Golgi complex. 
Background
Converging lines of evidence indicate that the secretory
pathway in mammals and yeast is regulated, at least in part,
through the production and consumption of lipid molecules
[1]. We have focused on a possible involvement of phos-
pholipase D (PLD) in membrane transport. PLD is acti-
vated by at least three classes of proteins: a small
GTP-binding protein termed ADP-ribosylation factor
(ARF); another small GTP-binding protein termed Rho;
and protein kinase C (PKC) [2–4]. PLD activation leads to
hydrolysis of phosphatidylcholine (PC) and production of
phosphatidic acid (PA). Our studies in vitro have so far sug-
gested that PLD is present on Golgi-enriched membranes,
and that its activation by ARF leads to the formation of
transport intermediates termed coated vesicles [5,6].
The lack of specific PLD inhibitors that are readily cell-
permeable complicates any efforts to pinpoint the exact role
of PLD in vivo. However, plant and mammalian PLD
enzymes undergo a transphosphatidylation reaction in the
presence of primary alcohols, whereby production of PA is
inhibited and a phosphatidyl alcohol product is formed
instead [7]. This property of PLD has been used in the past
to confirm the involvement of the lipase in certain pathways
[8–11]. We have already shown in vitro that ethanol inhibits
the formation of Golgi-coated vesicles. In this work, we
demonstrate that primary alcohols have an inhibitory effect
on the transport of glycoproteins in vivo. The site of the ear-
liest alcohol-induced transport block is at exit sites of the
endoplasmic reticulum (ER), and this inhibition can be
specifically reversed by exogenously added PA.
Results
Chinese hamster ovary (CHO) cells were infected with
the influenza virus, and the transport of the influenza
haemagglutinin (HA) glycoprotein was tracked by pulse-
chase radiolabeling with 35S-methionine and immunopre-
cipitation (Fig. 1). In the absence of any treatments during
the chase, HA was fully glycosylated and transported to
the Golgi complex after about 20 minutes (Fig. 1a and
[12]). When 3% ethanol was included during the chase,
HA transport to the Golgi was inhibited between two- and
five-fold (Fig. 1a, compare chase times of 10 and 20
minutes). In order to detect the appearance of HA at the
cell surface, trypsin was added during the chase, so that
the HA arriving at the plasma membrane would be
clipped into its two subunits, HA1 and HA2 (Fig. 1b and
[12]). Again, the presence of 3% ethanol during chase
inhibited transport of HA by three- to five-fold, and its
appearance at the cell surface by four- to fifteen-fold (Fig.
1b–d, compare ‘no treatment’ with ‘3% ethanol’).
If the alcohol-mediated block in transport of HA is due to
inhibition of PA formation by PLD, it should be possible
to assess the specificity of the block by comparing the
effects of primary alcohols, which are efficient substrates
for transphosphatidylation, with those of secondary alco-
hols, which are poor substrates. CHO cells were labeled
overnight with 3H-palmitate, and, at the end of the label-
ing step, the medium was changed to include the addition
of various alcohols and the cells were incubated for a
further 30 minutes. The labeled lipids were then extracted
and analyzed by thin layer chromatography (TLC). The
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region of the TLC plate that contained labeled phos-
phatidyl alcohols is shown in Figure 2a. Whereas the
primary alcohols (for example, butanol or propanol)
induced transphosphatidylation, the efficiency of this reac-
tion using the corresponding secondary alcohols (isobu-
tanol or isopropanol) was between five- and ten-fold lower.
Having established that the PLD activity in CHO cells has
the hallmark property of transphosphatidylation with
respect to alcohols, we measured the efficiency with which
these alcohols delayed the transport of HA (Fig. 2b).
Treatment with butanol and propanol inhibited transport
of HA by about five- to eight-fold, whereas isobutanol and
isopropanol at the same concentrations had little effect.
To determine the site of the alcohol block, we used the
temperature sensitive (ts)-O45 mutant vesicular stomatitis
virus (VSV) [13], the G glycoprotein of which is retained in
the ER at the nonpermissive temperature of 39.5°C, but
transported normally to the Golgi at 32°C [14]. CHO cells
were infected with ts-O45 VSV and kept at 39.5°C for 3.5
hours to allow VSV G to accumulate in the ER. The cells
were then shifted to 32°C in the presence of butanol or
isobutanol for 20 minutes, and the distribution of VSV G
assessed by indirect immunofluorescence (Fig. 3a–d). At
39.5°C, the glycoprotein was retained exclusively in the ER
(Fig. 3a, perinuclear and reticular morphology). Following
the shift to the lower temperature, the glycoprotein exited
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Figure 1
Ethanol delays the transport of influenza HA
from the ER to the Golgi complex and
subsequently to the cell surface. (a) CHO
cells in 6-well plates were infected with
influenza virus and transport of HA was
assayed 3.5 h after infection by radiolabeling
with Tran35Slabel for 5 min and chasing for
the indicated times in the presence or
absence of 3% ethanol. At the end of chase,
cells were lysed and HA was
immunoprecipitated and resolved by
SDS–PAGE (10% acrylamide). Ratios of ER
to Golgi forms of HA were determined by
phosphorimage analysis and percentages of
the Golgi form of HA are shown at the
bottom. (b) Transport of HA was assayed as
above with the following modification: trypsin
at 8 mg ml–1 was added during chase to
cleave the surface form of HA into its HA1
and HA2 subunits. Ratios of (c) Golgi or (d)
surface forms of HA from the experiment in (b)
were determined by phosphorimage analysis
and percentages are plotted.
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the ER and was transported to Golgi membranes (Fig. 3b,
intense punctate staining) where it colocalized with Golgi
enzymes such as mannosidase II (data not shown). When
1% butanol was present during the shift to the lower tem-
perature, the VSV G was retained in the ER (Fig. 3c). The
addition of isobutanol at 1% allowed VSV G to leave the
ER and be transported to the Golgi (Fig. 3d). In parallel
samples, the fate of VSV G during these treatments was
followed by radiolabeling and immunoprecipitation of this
glycoprotein (Fig. 3e). Following the shift to the lower
temperature, VSV G was transported to the Golgi complex
where it became resistant to digestion by endoglycosidase
H, which cleaves sugar groups from glycoproteins. The
acquisition of resistance to endoglycosidase H was
blocked completely by 1% butanol, but much less effec-
tively by 1% isobutanol.
That alcohols inhibit the exit of glycoproteins from the ER
to the same degree as they induce transphosphatidylation
by PLD suggests that the formation of PA is an important
requirement for this transport step. Thus, because PA, in
contrast to PC or phosphatidylethanolamine, can transfer
from exogenously supplied liposomes to the ER in CHO
cells [15,16], we attempted to prevent the alcohol block by
providing PA to the cells in the form of liposomes made by
sonication of PA phospholipids in the presence of defatted
bovine serum albumin (BSA) (Fig. 4). Using the method
described in Figure 3, transport of ts-O45 VSV G out of
the ER was followed during the shift to the permissive
temperature (Fig. 4a–d). Whereas 1% butanol blocked the
exit of the protein from the ER (Fig. 4c), the inclusion of
100 mM dilauroyl PA during the butanol treatment pre-
vented this transport block (Fig. 4d). The amount of VSV
G that redistributed from a reticular (ER-related) to a
punctate (vesicle- and Golgi-related) morphology under
the above treatments was quantified using a confocal
microscope (Fig. 4e). This procedure revealed that the
protein was able to exit quantitatively from the reticular
ER in the presence of butanol and PA; however, not all of
it localized to the Golgi complex. The efficiency with
which PA prevented the alcohol block and allowed trans-
port of the viral glycoproteins from the ER to the Golgi
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Figure 2
Primary, but not secondary, alcohols induce
transphosphatidylation by PLD and also inhibit
transport of HA from the ER to the Golgi
complex. (a) CHO cells in 6-well plates were
labeled overnight with 25 mg ml–1 of 3H-
palmitic acid. The cells were then washed and
fresh unlabelled medium containing alcohols
at the indicated concentrations was added for
a further 30 min. Lipids were extracted and
analyzed by TLC. The region of the TLC plate
that contains the phosphatidyl alcohol
products is shown. (b) Transport of influenza
HA to the Golgi complex was measured as in
Figure 1, following chase of 30 min in the
presence of alcohols at the indicated
concentrations. The data and standard
deviation from three experiments are plotted in
the graph.
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was also assessed biochemically. The addition of PA during
the chase with butanol allowed some, but not all, of the HA
to become fully processed after a 20 minute chase (Fig. 4f).
By the addition of PA, we have been able to prevent con-
sistently 25–50% of the butanol block, as measured by the
arrival of HA at the Golgi. Identical results were obtained
when following transport of the ts-O45 VSV G protein
(data not shown).
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Figure 3
Transport of ts-O45 VSV G from ER to Golgi at the permissive
temperature is blocked by butanol but is only marginally affected by
isobutanol. (a–d) CHO cells grown on coverslips were infected with ts-
O45 VSV and incubated at 39.5°C for 3.5 h to allow for the production
of VSV G. The cells were then incubated for an additional 20 min at
39.5°C (restrictive) or at 32°C (permissive) with 1% butanol or
isobutanol as indicated. At the end of these treatments, cells on
coverslips were fixed with methanol and stained for
immunofluorescence with monoclonal antibodies to VSV G. (e) CHO
cells infected with VSV ts-O45 as above were labeled with
Tran35Slabel for 10 min at 39.5°C and chased for 20 min at 39°C or
32°C with the indicated additions. At the end of these treatments, the
cells were lysed and the VSV G was immunoprecipitated, digested with
endoglycosidase H and resolved by SDS-PAGE. The fraction of VSV G
that was resistant to digestion by endoglycosidase H was determined
by densitometry. The average values from three experiments are shown.
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Figure 4
PA prevents the alcohol-induced block in transport of both ts-O45 VSV
G and influenza HA. (a–d) CHO cells were infected with ts-O45 VSV as
for Figure 3 and were shifted to the permissive temperature in medium
containing 1% butanol or 1% butanol and 100mM dilauroyl PA as
indicated [10,11]. The localization of VSV G was determined by
immunofluorescence as in Figure 3. (e) The amount of VSV G antigen
that redistributed from reticular to punctate morphology following
treatments as indicated. We took advantage of the fact that when VSV G
is present in the ER, it is dispersed and results in weaker fluorescence
(set to background) compared with when it is in vesicles and Golgi
stacks, where it produces small areas of intense fluorescence (pixels
above background). The actual values and standard deviation of the
samples were for the 39.5°C to 0°C shift (0.3 ± 0.2); the 39.5°C to
32°C shift (5.8 ± 0.6); the 39.5°C to 32°C shift in the presence of
butanol (0.2 ± 0.1); and the 39.5°C to 32°C shift in the presence of
butanol and PA (4.3 ± 0.6). (f) CHO cells infected with influenza as
described in Figure 1 were labeled with Tran35Slabel for 7 min and
chased for 20 min in medium containing 1% butanol, 100mM dilauroyl
PA or both as indicated [11]. At the end of the chase, HA was
immunoprecipitated and resolved by SDS–PAGE. Percentages of the
Golgi form of HA determined by densitometry are shown beneath the gel.
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To establish the identity of the punctate structures contain-
ing VSV G after PA-mediated rescue of the alcohol block,
cells treated as for Figure 4 were labeled for immunofluo-
rescence with antibodies to VSV G and a second antibody to
either mannosidase II (a medial Golgi enzyme) or p58 (a
protein localized to the intermediate compartment between
the ER and the Golgi complex [17,18]). The results are
shown in Figure 5. The punctate structures containing VSV
G also contained p58 in more than 90% of the samples
(compare Fig. 5a to Fig. 5b). In contrast, the colocalization
of VSV G with mannosidase II was minimal (compare Fig.
5c with Fig. 5d). We conclude that addition of PA during
the alcohol block allows VSV G to be transported quantita-
tively to the intermediate compartment, but that not all of
the protein can continue transport to the Golgi.
We have used a number of other phospholipids and
glycerides to try to prevent the alcohol-induced block,
including dioleoyl PA, dilauroyl dipalmitoyl and dioleoyl
PC, dipalmitoyl phosphatidylethanolamine and diacylglyc-
erol. Only the PA-containing compounds allowed transport
of VSV G out of the ER in the presence of alcohols (data not
shown). However, these compounds vary in their efficiency
of cell entry and in their ability to form stable liposomes,
and so the safest interpretation of this negative result is that
the mechanism of PA prevention of the alcohol block does
not involve sequestration of the alcohol by liposomes. 
Discussion
We have presented complementary evidence that PLD
and its lipid product, PA, are required in the secretory
pathway at the level of exit from the ER. First, primary
alcohols inhibited transport from the ER to the same
degree to which they induced transphosphatidylation by
PLD. In addition, secondary alcohols, which are poor sub-
strates for transphosphatidylation, were equally less effec-
tive at blocking transport. This correlation rules out some
well-known non-specific alcohol effects and points to PLD
as being a potential mediator of the alcohol block. Second,
alcohol inhibition was reversed by the exogenous addition
of PA liposomes. This reversal was specific for PA and was
not seen when other phospholipids were used. Dilauroyl
PA (C 12:0) was more effective than dioleloyl PA (C 18:0) in
preventing the butanol block, probably because the former
can enter cells more readily. We argue that the specificity of
the alcohol block and its reversal by PA are consistent with
a role for PLD in ER-to-Golgi transport. It is interesting to
note that, in our model system, PLD activity is constitutive,
because no activators of the enzyme are used. This suggests
that the enzyme in its basal state may mediate the ‘house-
keeping’ function of secretion, in addition to its known
activities upon stimulation.
Exit from the ER is mediated by at least two distinct
protein complexes that are thought to form vesicle coats
[19]. One of them, COPII, was first identified by genetic
and biochemical analyses in yeast, but mammalian
homologs also exist. The binding of COPII to membranes
for initiation of transport is mediated by Sar1p, a small
GTP-binding protein [20]. As Sar1p is not known to acti-
vate PLD, it is unclear what relevance COPII has in the
alcohol-mediated transport block and the requirement for
PA in glycoprotein transport reported in this paper.
Another coat complex involved in ER-to-Golgi transport is
COPI. The binding of COPI to membranes and the initia-
tion of transport is regulated by ARF [21]. Because ARF is
also the most efficacious activator of PLD, we suggest that
alcohols block the ARF-dependent exit from the ER,
independently of whether ARF acts directly or indirectly
on ER exit. The exact site of ARF and COPI action in this
pathway is a matter of debate [22]. Some evidence shows
that antibodies to a COPI subunit (b-cop) inhibit exit of
ts-O45 VSV G from the ER in permeabilized cells, and
that a GTP-activated form of ARF can stabilize this step
[23,24]. More recent work has suggested that this inhibi-
tion may be indirect, and that the primary function of
COPI may be to mediate anterograde transport from
export sites of the ER termed vesicular tubular clusters
(VTCs) [25]. In this view, anterograde and retrograde
traffic is coupled at the VTCs, and inhibition of antero-
grade transport by agents that interfere with COPI func-
tion may be an indirect consequence of blocking
COPI-mediated retrograde transport. If this model is
correct, our results suggest that activation of PLD may be
a mechanism for ‘re-addressing’ vesicles that originated
from the ER, but must now return to it rather than
continue on to the Golgi complex. 
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Figure 5
The punctate distribution of VSV G after rescue of alcohol block with PA
corresponds to the localization of VSV G to the intermediate
compartment. After rescue of the butanol-induced block in transport of
VSV G by PA, the samples were coimmunostained with (a,c) antibodies
to VSV G and (b) antibodies to p58 or (d) antibodies to mannosidase II
(Man II). Note the colocalization of VSV G and p58 in (a,b).
The reason the PA requirement is at present unknown.
Pagano and colleagues [15,16] have shown using fluores-
cent derivatives of PA that this lipid is rapidly and effi-
ciently transferred from exogenous liposomes into the
nuclear membrane, ER and mitochondria of CHO cells,
even during incubation at 2°C. Upon a temperature shift
to 37°C, staining of PA within the ER was reduced, and
fluorescent lipid droplets in the cytoplasm appeared,
demonstrating that the fluorescent PA and its derivatives
did not follow the secretory pathway. This probably
explains why PA-mediated exit from the ER in the pres-
ence of alcohols was more efficient than subsequent trans-
port to the Golgi in our experiments: at the ER, there
should be an adequate supply of exogenous PA, but for
the subsequent transport step(s) from the intermediate
compartment to the Golgi, exogenous PA is probably lim-
iting because it does not track with secretory material. But
exactly how is PA used? It is possible that PA is needed as
an intermediate for formation of other molecules, such as
diacylglycerol [15,16] or lyso-PA. Alternatively, it is possi-
ble that PA itself is a critical determinant of formation of
transport intermediates. This question can now be
addressed using the experimental paradigm that we have
described. 
Materials and methods
Tissue culture and materials
CHO K1 cells were grown at 37°C in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 5% fetal bovine serum (Hyclone),
0.35 mM proline, 50 U ml–1 penicillin, 50 mg ml–1 streptomycin, 1 mM
sodium pyruvate and 10 mM Hepes (pH 7.3). All chemicals (including
the various lipids) were from Sigma unless noted otherwise.
Antibodies
The rabbit anti-mannosidase II antibody was purchased from K.
Moremen; the monoclonal antibody M3A5 to b-cop was a gift from T.
Kreiss; the rabbit anti-p58 was a gift from J. Saraste; the monoclonal
antibody FC-125 to influenza HA was a gift from T. Braciale; and the
monoclonal antibody BW to VSV G was a gift from B. Balch.
Infection with virus and radiolabelling
CHO K1 cells on coverslips or on 6-well plates were infected with the
indicated viruses usually for 3.5 h, and were then processed for immuno-
fluorescence or pulse-chase studies as previously described [26].
Lipid analysis
CHO K1 cells were plated on 6-well plates so that they were 90% con-
fluent on the day of the experiment. They were washed twice in serum-
free DMEM and were labeled for 16–18 h with 25mg ml–1 of 3H-palmitic
acid in DMEM containing 1% serum. The following day, the cells were
washed and fresh medium without label but with alcohols at the indi-
cated concentrations was added for 30 min. At the end of 30 min, cellu-
lar lipids were extracted essentially according to Bligh and Dyer [27] as
follows: cells were washed with ice-cold PBS and were extracted with
1.2 ml methanol/PBS solution at 2:1 ratio. The cells extracts were
scraped and transferred into a glass tube, and 0.4 ml of chloroform was
added for 30 min at room temperature. Following centrifugation for 5 min
at 3000 × g to pellet cell debris, the clear supernatant was transferred to
a new tube and 0.5 ml chloroform and 0.4 ml 23 mM HCl was added to
produce an aqueous and an organic phase. The phases were separated
by centrifugation at 3000 × g for 5 min, the aqueous phase was dis-
carded and the organic phase containing the lipids was concentrated
10-fold by evaporation. The solution containing lipids was loaded onto
TLC plates (LK6DF, Whatman) and resolved in a solvent system of chlo-
roform:methanol:acetic acid:acetone:water at 270:54:54:108:27 vol/vol
ratios. The lipid bands were visualized by autoradiography and analyzed
using a scanning densitometer (Molecular Dynamics).
PA rescue experiments
Phospholipids were kept as 10 mg ml–1 solutions in chloroform at
–20°C in a dry atmosphere. To make liposomes, the appropriate
volume of stock solution was placed in glass tubes (prewashed with
chloroform) and dried under nitrogen gas. The dried lipid was resus-
pended in 600 ml of 0.5% defatted BSA in PBS and sonicated for
5 min. This solution was used as a 5× stock, and was supplemented
with DMEM and alcohol where appropriate, keeping the BSA concen-
tration at 0.5%. Vesicle preparations were used within 2 h of prepara-
tion. Control solutions (with no phospholipid) were prepared by drying
the equivalent volume of chloroform and following the same steps as
above, including sonication of the BSA solution. PA rescue experi-
ments were done as follows: following labeling with 35S (for HA) or
incubation at 39.5°C (for ts-O45 VSV), PA-vesicle solution was added
to the samples, which were placed on ice for 30 min. At the end of
30 min, the PA solution was removed and fresh solution (usually at half
the original concentration) with alcohols where appropriate was added.
The samples were then incubated at 32°C (for ts-O45 VSV) or 37°C
(for HA) for an additional 20 min. In pilot experiments, we found that
preincubation with PA liposomes on ice rather than simultaneous addi-
tion with the alcohols prevented the alcohol-induced transport block
more efficiently.
Quantitative confocal microscopy
Quantitative immunofluorescence was performed using a Bio-Rad
MRC600 laser-scanning confocal unit. All samples to be quantitated
were stained with antibodies to VSV G and an appropriate secondary
antibody. The photomultiplier gains of the scanning head were set so
that the average pixel intensity of cells that were shifted directly from
39.5°C to 0°C was very low: this defined the value for background
immunofluorescence. We then took a series of images of cells treated
as indicated at zoom 1, and using the Band subroutine of the confocal
software we measured the area of the image with pixels of fluores-
cence intensity above the background. The Stats command of the soft-
ware was then used to determine the percentage of total pixels of each
image containing an intensity above background. For each treatment
shown in Figure 4e, 6–7 images, each of 150 cells were collected.
Acknowledgements
We thank Paul Sternweis and Alex Brown for useful discussions. This work
was supported by an NIH grant to M.G.R., and an AHA Texas Affiliate grant
to N.T.K.
References
1. De Camilli P, Emr SD, McPherson PS, Novick P: Phosphoinositides
as regulators in membrane traffic. Science 1996, 271:1533–1539.
2. Brown HA, Gutowski S, Moomaw CR, Slaughter C, Sternweis PC:
ADP-ribosylation factor (ARF), a small GTP-dependent regulatory
protein, stimulates phospholipase D activity. Cell 1993,
75:1137–1144.
3. Cockcroft S, Thomas GM, Fensome A, Geny B, Cunningham E, Gout
I, Hiles I, Totty NF, Truong O, Hsuan JJ: Phospholipase D: a
downstream effector of ARF in granulocytes. Science 1994,
263:523–526.
4. Singer WD, Brown HA, Jiang XJ, Sternweis PC: Regulation of
phospholipase D by protein kinase C is synergistic with ADP-
ribosylation factor and independent of protein kinase activity. J
Biol Chem 1996, 271:4504–4510.
5. Ktistakis NT, Brown HA, Sternweis PC, Roth MG: Phospholipase D
is present on Golgi-enriched membranes and its activation by
ADP ribosylation factor is sensitive to brefeldin A. Proc Natl Acad
Sci USA 1995, 92:4952–4956.
6. Ktistakis NT, Brown HA, Waters MG, Sternweis PC, Roth MG:
Evidence that phospholipase D mediates ADP ribosylation factor-
dependent formation of coated vesicles. J Cell Biol 1996,
134:295–306.
306 Current Biology, Vol 7 No 5
7. Heller M: Phospholipase D. Adv Lipid Res 1978, 16:267–326.
8. Stutchfield J, Cockcroft S: Correlation between secretion and
phospholipase D activation in differentiated HL60 cells. Biochem J
1993, 293:649–655.
9. Ben-Av P, Eli Y, Schmidt US, Tobias K, Liskovitch M: Distinct
mechanisms of phospholipase D activation and attenuation
utilized by different mitogens in NIH-3T3 fibroblasts. Eur J
Biochem 1993, 215:455–463.
10. Moehren G, Gustavsson L, Hoek JB: Activation and desensitization
of phospholipase D in intact hepatocytes. J Biol Chem 1994,
269:838–848.
11. Cross MJ, Roberts S, Ridley AJ, Hodgin MN, Stewart A, Claesson-
Welsh L, Wakelam MJO: Stimulation of actin stress fibre formation
mediated by activation of phospholipase D. Curr Biol 1996,
6:588–597.
12. Lazarovits J, Shia SP, Ktistakis N, Lee MS, Bird C, Roth M: The
effects of foreign transmembrane domains on the biosynthesis of
the influenza virus hemagglutinin J Biol Chem 1990,
265:4760–4767.
13. Lafay F: Envelope proteins of vesicular stomatitis virus: effect of
temperature-sensitive mutations in complementation groups III
and V. J Virol 1974, 14:1220–1228.
14. Bergman JE: Using temperature-sensitive mutants of VSV to study
membrane protein biogenesis. Methods Cell Biol 1989,
32:85–110.
15. Pagano RE, Longmuir KL, Martin OC, Struck DK: Metabolism and
intracellular localization of a fluorescently labeled intermediate in
lipid biosynthesis within cultured fibroblasts. J Cell Biol 1981,
91:872–877.
16. Pagano RE, Longmuir KJ, Martin OC: Intracellular translocation and
metabolism of a fluorescent phosphatidic acid analogue in
cultured fibroblasts. J Biol Chem 1983, 258:2034–2040.
17. Saraste J, Kuismanen E: Pre- and post-Golgi vacuoles operate in
the transport of Semliki Forest virus membrane glycoproteins to
the cell surface. Cell 1984, 38:535–549.
18. Saraste J, Svensson K: Distribution of the intermediate elements
operating in ER to Golgi transport. J Cell Sci 1991, 100:415–430.
19. Schekman R, Orci L: Coat proteins and vesicle budding. Science
1996, 271:1526–1533.
20. Oka T, Nishikawa SI, Nakano A: Reconstitution of GTP-binding Sar1
protein function in ER to Golgi transport. J Cell Biol 1991,
114:671–679.
21. Donaldson JG, Cassel D, Kahn RA, Klausner RD: ADP- ribosylation
factor, a small GTP-binding protein, is required for binding of the
coatomer protein beta-cop to Golgi membranes. Proc Natl Acad
Sci USA 1992, 89:6408–6412.
22. Pelham HRB: About turn for the COPs? Cell 1994, 79:1125–1127.
23. Peter F, Plutner H, Zhu H, Kreiss TE, Balch WE: Beta-COP is
essential for transport of protein from the endoplasmic reticulum
to the Golgi in vitro. J Cell Biol 1993, 122:1155–1167.
24. Aridor M, Bannykh SI, Rowe T, Balch WE: Sequential coupling
between COPII and COPI vesicle coats in endoplasmic reticulum
to Golgi transport. J Cell Biol 1995, 131:875–893.
25. Bannykh SI, Rowe T, Balch WE: The organization of endoplasmic
reticulum export complexes. J Cell Biol 1996, 135:19–35.
26. Ktistakis NT, Kao CY, Wang RH, Roth MG: A fluorescent lipid
analogue can be used to monitor secretory activity and for
isolation of mammalian secretion mutants. Mol Biol Cell 1995,
6:135–150.
27. Bligh EG, Dyer WJ: Lipid extraction. Can J Biochem Physiol 1959,
37:911–917.
Research Paper  PLD in ER-to-Golgi transport Bi et al. 307
Because Current Biology operates a ‘Continuous Publication
System’ for Research Papers, this paper has been published
via the internet before being printed. The paper can be
accessed from http://biomednet.com/cbiology/cub — for
further information, see the explanation on the contents page.
